Correlation Between Edgewise Therapeutics and Minerva Neurosciences

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Edgewise Therapeutics and Minerva Neurosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Edgewise Therapeutics and Minerva Neurosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Edgewise Therapeutics and Minerva Neurosciences, you can compare the effects of market volatilities on Edgewise Therapeutics and Minerva Neurosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Edgewise Therapeutics with a short position of Minerva Neurosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Edgewise Therapeutics and Minerva Neurosciences.

Diversification Opportunities for Edgewise Therapeutics and Minerva Neurosciences

-0.66
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Edgewise and Minerva is -0.66. Overlapping area represents the amount of risk that can be diversified away by holding Edgewise Therapeutics and Minerva Neurosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Minerva Neurosciences and Edgewise Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Edgewise Therapeutics are associated (or correlated) with Minerva Neurosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Minerva Neurosciences has no effect on the direction of Edgewise Therapeutics i.e., Edgewise Therapeutics and Minerva Neurosciences go up and down completely randomly.

Pair Corralation between Edgewise Therapeutics and Minerva Neurosciences

Given the investment horizon of 90 days Edgewise Therapeutics is expected to generate 1.08 times more return on investment than Minerva Neurosciences. However, Edgewise Therapeutics is 1.08 times more volatile than Minerva Neurosciences. It trades about 0.13 of its potential returns per unit of risk. Minerva Neurosciences is currently generating about -0.03 per unit of risk. If you would invest  687.00  in Edgewise Therapeutics on September 2, 2024 and sell it today you would earn a total of  2,613  from holding Edgewise Therapeutics or generate 380.35% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Edgewise Therapeutics  vs.  Minerva Neurosciences

 Performance 
       Timeline  
Edgewise Therapeutics 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Edgewise Therapeutics are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Edgewise Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.
Minerva Neurosciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Minerva Neurosciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in January 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

Edgewise Therapeutics and Minerva Neurosciences Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Edgewise Therapeutics and Minerva Neurosciences

The main advantage of trading using opposite Edgewise Therapeutics and Minerva Neurosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Edgewise Therapeutics position performs unexpectedly, Minerva Neurosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Minerva Neurosciences will offset losses from the drop in Minerva Neurosciences' long position.
The idea behind Edgewise Therapeutics and Minerva Neurosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.

Other Complementary Tools

Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum